These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 10436417

  • 1. Skin metastases of gynecologic adenocarcinomas affect serum levels of hCGbeta but not those of SCC antigen.
    Lehtovirta P, Alfthan H, Vartiainen J, Stenman U.
    Tumour Biol; 1999; 20(5):251-5. PubMed ID: 10436417
    [Abstract] [Full Text] [Related]

  • 2. Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx.
    Hedström J, Grenman R, Ramsay H, Finne P, Lundin J, Haglund C, Alfthan H, Stenman UH.
    Int J Cancer; 1999 Oct 22; 84(5):525-8. PubMed ID: 10502732
    [Abstract] [Full Text] [Related]

  • 3. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D, Hirasawa A, Susumu N.
    Gan To Kagaku Ryoho; 2005 Mar 22; 32(3):411-6. PubMed ID: 15791829
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. SCC antigen in malignant and nonmalignant squamous lesions.
    Torre GC.
    Tumour Biol; 1998 Mar 22; 19(6):517-26. PubMed ID: 9817981
    [Abstract] [Full Text] [Related]

  • 6. Clinical value of squamous cell carcinoma antigen (SCC-A) in Egyptian gynecologic cancer patients.
    Salman T, el-Ahmady O, Tony O, Darwish M.
    Anticancer Res; 1997 Mar 22; 17(4B):3083-6. PubMed ID: 9329607
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
    Davelaar EM, van de Lande J, von Mensdorff-Pouilly S, Blankenstein MA, Verheijen RH, Kenemans P.
    Tumour Biol; 2008 Mar 22; 29(1):9-17. PubMed ID: 18497544
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
    Tabata T, Takeshima N, Tanaka N, Hirai Y, Hasumi K.
    Tumour Biol; 2000 Mar 22; 21(6):375-80. PubMed ID: 11006578
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preoperative serum hCGbeta as a prognostic marker in primary fallopian tube carcinoma.
    Riska A, Alfthan H, Finne P, Jalkanen J, Sorvari T, Stenman UH, Leminen A.
    Tumour Biol; 2006 Mar 22; 27(1):43-9. PubMed ID: 16340249
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic significance of serum squamous cell carcinoma antigen in surgically treated lung cancer.
    Takeuchi S, Nonaka M, Kadokura M, Takaba T.
    Ann Thorac Cardiovasc Surg; 2003 Apr 22; 9(2):98-104. PubMed ID: 12732086
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies.
    Scambia G, Benedetti Panici P, Perrone L, Sonsini C, Giannelli S, Gallo A, Natali PG, Mancuso S.
    Br J Cancer; 1990 Jul 22; 62(1):147-51. PubMed ID: 2167724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.